Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schellhammer

Showing results (211-220 of 326) with videos related to

Pageof 33
Sort By:
Radiology|February 1, 1995
Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapyJ A Kim, D A Kuban, A M el-Mahdi, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1984
Triple course external beam radiotherapy for carcinoma of the prostateA M El-Mahdi, C I Turalba, P F Schellhammer, et al.
The Journal of Urology|May 11, 1992
The detection of prostate specific antigen, MHS-5, and other markers in invasive prostate cancer and seminal vesicleB M Grob, C Haley, P F Schellhammer, et al.
The Journal of Urology|July 1, 1993
Deoxyribonucleic acid cytometric analysis of prostate core biopsy specimens: relationship to serum prostate specific antigen and prostatic acid phosphatase, clinical stage and histopathologyA M Konchuba, P F Schellhammer, P Kolm, et al.
The Prostate|August 1, 1997
Serum levels of endothelial and neural cell adhesion molecules in prostate cancerD F Lynch, W Hassen, M A Clements, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Prostate-specific membrane antigen levels in sera from healthy men and patients with benign prostate hyperplasia or prostate cancerM L Beckett, L H Cazares, A Vlahou, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 30, 1999
Prostatic carcinomaC A Lawton, D Grignon, J H Newhouse, et al.
Urology|July 1, 1993
Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostateP F Schellhammer, A M el-Mahdi, G L Wright, et al.
Urology|December 1, 1990
Are three substages of clinical B prostate carcinoma useful in predicting disease-free survival?A J Glick, C B Philput, A el Mahdi, et al.
Seminars in Urologic Oncology|May 1, 1997
Summary of transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer (by Paul F. Schellhammer, MD, and Willet F. Whitmore, Jr, MD). 1976P F Schellhammer, W Mardovin, N S Davis, et al.
Pageof 33

Showing results (211-220 of 326) with videos related to

Sort By:
Pageof 33
Radiology|February 1, 1995
Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapyJ A Kim, D A Kuban, A M el-Mahdi, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1984
Triple course external beam radiotherapy for carcinoma of the prostateA M El-Mahdi, C I Turalba, P F Schellhammer, et al.
The Journal of Urology|May 11, 1992
The detection of prostate specific antigen, MHS-5, and other markers in invasive prostate cancer and seminal vesicleB M Grob, C Haley, P F Schellhammer, et al.
The Journal of Urology|July 1, 1993
Deoxyribonucleic acid cytometric analysis of prostate core biopsy specimens: relationship to serum prostate specific antigen and prostatic acid phosphatase, clinical stage and histopathologyA M Konchuba, P F Schellhammer, P Kolm, et al.
The Prostate|August 1, 1997
Serum levels of endothelial and neural cell adhesion molecules in prostate cancerD F Lynch, W Hassen, M A Clements, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Prostate-specific membrane antigen levels in sera from healthy men and patients with benign prostate hyperplasia or prostate cancerM L Beckett, L H Cazares, A Vlahou, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 30, 1999
Prostatic carcinomaC A Lawton, D Grignon, J H Newhouse, et al.
Urology|July 1, 1993
Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostateP F Schellhammer, A M el-Mahdi, G L Wright, et al.
Urology|December 1, 1990
Are three substages of clinical B prostate carcinoma useful in predicting disease-free survival?A J Glick, C B Philput, A el Mahdi, et al.
Seminars in Urologic Oncology|May 1, 1997
Summary of transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer (by Paul F. Schellhammer, MD, and Willet F. Whitmore, Jr, MD). 1976P F Schellhammer, W Mardovin, N S Davis, et al.
Pageof 33